首页> 外文期刊>RSC Advances >Formation of drug nanocrystals under nanoconfinement afforded by liposomes
【24h】

Formation of drug nanocrystals under nanoconfinement afforded by liposomes

机译:在脂质体提供的纳米胺下的药物纳米晶体形成

获取原文
           

摘要

Nanocrystals of drug substances have important therapeutic applications, but their preparation is often difficult due to size control in bottom up approaches, or energetic milling and surface activation in top down processing. In this study, confinement within liposome nanocompartments is demonstrated to enable drug crystallization with a high aspect ratio but limited growth resulting in nanocrystals, using a simple freeze–thaw process which is anticipated to be amenable to large scale preparation. After the freeze–thaw, cryo-transmission electron microscopy (cryoTEM) imaging and cryo-electron tomography revealed that the majority of the liposomes contained a single drug nanocrystal, observed to physically stretch but not burst the liposomes, and the composition of the freeze–thaw medium altered the aspect ratio of the drug nanocrystals. Small angle X-ray scattering and dynamic depolarized light scattering were used to confirm the asymmetric nature of particles in suspension to exclude the cryoTEM preparation process as a contributor to the particle morphology. In assessing potential use in controlled release drug delivery, the in vitro release rate of ciprofloxacin from liposomes containing the nanocrystals revealed that the rate of dissolution of the nanocrystals became the rate controlling step, in contrast to the lipid bilayer rate controlling function prior to the formation of the crystals. The ability to modulate the release rate of the active ingredient in a complex formulation using simple physical means ( e.g. , freeze/thaw) is an attractive possibility, especially in highly regulated industries such as pharmaceuticals where qualitative and quantitative changes of composition would require extensive safety evaluations.
机译:药物物质的纳米晶体具有重要的治疗应用,但由于底部接近的尺寸控制,或顶部下降处理中的精力铣削和表面激活,它们的制备往往是困难的。在该研究中,对脂质体纳米组分的限制进行了说明,以使药物结晶能够使用高纵横比但使用简单的冻融工艺导致纳米晶体产生的有限的生长,这预计将允许适用于大规模制剂。在冻融之后,冷冻透射电子显微镜(Cryotem)成像和冷冻电子断层摄影显示大多数脂质体含有单个药物纳米晶体,观察到物理拉伸但不突发脂质体,以及冻结的组成 - 解冻介质改变了药物纳米晶体的纵横比。小角度X射线散射和动态去极光散射用于确认悬浮液中颗粒的不对称性质,以将Cryotem制备过程排除为颗粒形态的贡献者。在评估控制释放药物递送中的潜在用途时,含有纳米晶体脂质体的环丙沙星的体外释放速率显示,纳米晶体的溶解速率变成速率控制步骤,与形成之前的脂质双层速率控制功能相反晶体。使用简单的物理手段(例如,冷冻/解冻)在复杂配方中调节活性成分的释放速率的能力是一种有吸引力的可能性,特别是在高度监管的行业,例如药品,其中组合物的定性和定量变化需要广泛的安全性评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号